SUBSCRIBERS
Bayer's magic formula in Singapore - open collaboration
Public-private partnerships the key, especially in clinical research' spending S$27 million over 10 years
Add BT as a preferred source
Published Tue, Apr 17, 2018 · 09:50 PM
Singapore
BAYER'S absence last year from an industry manufacturing consortium did not mean that it snubbed partnerships in the Republic, said the German giant's top drugs man here.
Claus Zieler, Bayer Pharmaceuticals' senior vice-president and head of commercial operations in the Asia-Pacific, told The Business Times that the company is open to tie-ups, including in the private sector.
Copyright SPH Media. All rights reserved.
